| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 114.71▲ | 114.63▲ | 114.63▲ | 114.63▲ | 114.56▲ |
| MA10 | 114.69▲ | 114.65▲ | 114.64▲ | 114.59▲ | 95.55▲ |
| MA20 | 114.65▲ | 114.64▲ | 114.59▲ | 114.47▲ | 82.79▲ |
| MA50 | 114.65▲ | 114.57▲ | 114.55▲ | 92.33▲ | 76.76▲ |
| MA100 | 114.65▲ | 114.54▲ | 114.49▲ | 83.02▲ | 73.31▲ |
| MA200 | 114.59▲ | 114.48▲ | 108.92▲ | 78.78▲ | 55.03▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.010▲ | 0.002▲ | 0.007▲ | -1.616▼ | 4.990▲ |
| RSI | 64.021▲ | 62.460▲ | 60.020▲ | 81.456▲ | 74.281▲ |
| STOCH | 70.370 | 29.414 | 39.579 | 54.443 | 99.369▲ |
| WILL %R | -8.333▲ | -29.630 | -23.529▲ | -26.154 | -0.312▲ |
| CCI | 149.249▲ | 107.397▲ | 119.266▲ | 116.687▲ | 78.573 |
|
Monday, March 16, 2026 06:11 PM
Arcellx develops cell-based immunotherapies for cancer, leveraging proprietary platforms to address high unmet needs in oncology.
|
|
Tuesday, March 10, 2026 12:35 AM
Arcellx, Inc. (NASDAQ:ACLX) is among the 12 Best Performing Stocks in February. On February 23, 2026, CNBC reported that Gilead Sciences announced it would acquire Arcellx, Inc. (NASDAQ:ACLX) for up ...
|
|
Thursday, March 05, 2026 10:36 AM
The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/03/26 | 114.64 | 114.75 | 114.63 | 114.74 | 250,652 |
| 27/03/26 | 114.62 | 114.82 | 114.54 | 114.57 | 1,648,736 |
| 26/03/26 | 114.55 | 114.77 | 114.47 | 114.62 | 1,201,582 |
| 25/03/26 | 114.58 | 114.70 | 114.47 | 114.54 | 1,122,558 |
| 24/03/26 | 114.68 | 114.70 | 114.3995 | 114.69 | 1,597,489 |
| 23/03/26 | 114.54 | 114.74 | 114.48 | 114.60 | 1,236,752 |
| 20/03/26 | 114.60 | 114.91 | 114.34 | 114.77 | 3,173,199 |
| 19/03/26 | 114.55 | 114.74 | 114.30 | 114.33 | 1,435,050 |
| 18/03/26 | 114.46 | 114.77 | 114.36 | 114.51 | 2,025,556 |
| 17/03/26 | 114.42 | 114.62 | 114.40 | 114.52 | 691,985 |
|
|
||||
|
|
||||
|
|